<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Granulocyte-macrophage colony-stimulating factor (GM-CSF/CSF2) is a cytokine produced in the hematologic compartment that may enhance antitumor immune responses, mainly by activation of dendritic cells </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we show that more than one-third of human <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> exhibit aberrant DNA demethylation of the GM-CSF promoter and overexpress the cytokine </plain></SENT>
<SENT sid="2" pm="."><plain>Mouse engraftment experiments with autologous and homologous <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> engineered to repress the ectopic secretion of GM-CSF revealed the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-secreted GM-CSF to have an immune-associated antitumor effect </plain></SENT>
<SENT sid="3" pm="."><plain>Unexpectedly, an immune-independent antitumor effect was observed that depended on the ectopic expression of GM-CSF receptor subunits by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> cells expressing GM-CSF and its receptor did not develop into <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> when autografted into immunocompetent mice </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, 100% of the patients with human <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> that overexpressed GM-CSF and its receptor subunits survived at least 5 years after diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain>These data suggest that expression of GM-CSF and its receptor subunits by <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> may be a useful marker for prognosis as well as for patient stratification in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> immunotherapy </plain></SENT>
</text></document>